共 74 条
[1]
Van den Bergh PYK(2021)European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision J Peripher Nerv Syst 26 242-268
[2]
van Doorn PA(2019)Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy The Lancet Neurology 18 784-794
[3]
Hadden RDM(2007)Pathogenesis and clinical features of psoriasis The Lancet 370 263-271
[4]
Avau B(2015)Psoriasis The Lancet 386 983-994
[5]
Vankrunkelsven P(2006)Psoriasis improved by intravenous immunoglobulin therapy Intern Med 45 879-880
[6]
Allen JA(2014)Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis Br J Dermatol 170 206-209
[7]
Bunschoten C(2016)The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris Eur J Dermatol 26 404-405
[8]
Jacobs BC(2018)Therapeutic Mechanisms of Glucocorticoids Trends Endocrinol Metab 29 42-54
[9]
Van den Bergh PYK(2019)Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment J Neurol Neurosurg Psychiatry 90 981-987
[10]
Cornblath DR(2019)Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease J Autoimmun 102 8-37